Related Experiment Videos
Current status and future expectations for multisite pacing in heart failure
Eduardo B Saad1, Bruce L Wilkoff
1Department of Cardiovascular Medicine, Section of Cardiac Pacing and Electrophysiology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F15, Cleveland, OH 44122, USA.
Insights
Congestive heart failure (CHF) is a major health burden. Multisite cardiac pacing offers a promising therapy for severe CHF patients unresponsive to medical treatments, though patient selection and technical aspects require further development.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Congestive heart failure (CHF) affects a large patient population, leading to significant morbidity, mortality, and healthcare costs.
- Current medical therapies and heart transplantation have limitations in improving prognosis for many CHF patients.
Purpose of the Study:
- To review the rationale, delivery methods, and supporting data for multisite cardiac pacing in treating severe, medically refractory CHF.
- To highlight the potential of multisite pacing as an alternative therapeutic approach for the failing heart.
Main Methods:
- Review of existing literature on multisite cardiac pacing for congestive heart failure.
- Analysis of technical considerations and patient selection strategies for biventricular pacing.
Main Results:
- Biventricular pacing shows promise for severe CHF patients with ventricular conduction defects.
- Technical challenges and optimal patient selection criteria for multisite pacing are still under development.
Conclusions:
- Multisite cardiac pacing is an emerging therapeutic option for advanced congestive heart failure.
- Further research is needed to refine techniques and identify ideal candidates for this intervention.
Abstract:
The number of patients with congestive heart failure (CHF) has achieved astonishing proportions. It is a debilitating and usually lethal condition, aside from being responsible for an enormous proportion of health care expenditures. Advances in medical therapy have not been sufficient to significantly improve prognosis, and heart transplantation can only benefit a minority of patients. Biventricular pacing has emerged as a promising form of therapy for patients with severe, medical refractory CHF with ventricular conduction defects. However, there are many technical issues to be solved, and better methods of selecting patients who respond favorably to this form of therapy are yet to be developed. This article reviews the rationale, delivery modes, and available data supporting multisite cardiac pacing as an alternative form of therapy for the failing heart.